Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses - Wikidata - awgldk - TriplyDB

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

http://www.wikidata.org/entity/Q26851802

about

Immune checkpoint inhibitor therapy associated hypophysitis Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents Advances in understanding autoimmune pituitary disease: standardized methods for autoantibody detection.History and current state of immunotherapy in glioma and brain metastasis.Novel anti-melanoma treatment: focus on immunotherapy.Ipilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesions Ipilimumab-induced hypophysitis: review of the literature.Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer.pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis.Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.Late endocrine effects of childhood cancer.Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies Risk of endocrine adverse events in cancer patients treated with PD-1 inhibitors: a systematic review and meta-analysis.Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry.Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review.Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy.

P2860

Q26827140-5BAD9C15-456B-4F83-B625-A630E9B1A782 Q28079455-674C0694-F4A3-49D7-9B29-0671C81650FC Q33568973-5C964C1A-EAB5-420C-9E9D-61B35E05FDF6 Q33656811-6B886573-18DA-4469-87B8-C3B66C906206 Q34309404-6FB733CE-D5FC-4881-AD43-CE0F7D1B9C44 Q34769437-DEBDCD00-AE05-4E51-9726-CB1088E8A0A1 Q38469194-6C9C2C51-9BFF-4C6A-8024-833C5C67A249 Q38502692-9B342325-DD31-4AD8-B916-45513B7E63A9 Q38673109-19039BAF-6F60-4812-9DDA-06DE760AC030 Q38694640-8A3222C8-8F16-4F49-8A9A-EF3E02FEF1A5 Q38699309-3FBF0470-9ED2-4846-825D-13C8AA1C902B Q38783026-BB93282C-B2B0-4363-A60B-521005CB8E00 Q38794942-7D5177AB-EE2A-4B46-B24A-906E0180DD00 Q38882247-0A4A5783-AFB2-42DF-B691-BDC8BC40DC9F Q38915592-333528A4-280D-4684-A595-ED5ABB286DDE Q39010566-6095095C-4CD3-4D9B-90FE-01347F320034 Q39148284-0CA5ADB9-E27C-459A-B315-E8BB32008AD0 Q39947131-36FE5BB9-9229-42FB-9A4F-2A2077B1C2F5 Q47287952-9825A482-37A0-45A8-B9F5-1159FAB922E6 Q47707565-14916393-0F7E-4AC6-AA3F-744AE87C3F81 Q53552401-60910ACD-A2AB-4324-B4EC-A36008EEA417 Q55378086-CE6452BF-162F-48DD-B4D2-52E2C2EDBDCB

P2860

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

http://www.wikidata.org/entity/Q26851802

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@ast

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@en

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@nl

type

label

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@ast

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@en

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@nl

prefLabel

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@ast

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@en

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@nl

P1433

Q26851802-25B55EB4-426D-4B63-9F5B-045C8AC0EEC2

P1476

Q26851802-D2FFBB04-AC4A-4613-AE6B-E60F67176C3F

P2093

Q26851802-08BD89D1-8528-4C47-B278-37985193342D

Q26851802-139F38E4-D038-4161-B440-7CEDD0562B50

Q26851802-1534C2B7-810F-4414-ABA9-7D725A9AD307

Q26851802-78371D63-13AD-48A9-A62F-ACB6D663C957

P304

Q26851802-7ED444B6-92D5-4382-9792-60B4B1DC1D18

P31

Q26851802-1801E03E-B439-406C-9BF0-62DDB925005D

P3181

Q26851802-C11A7169-7AFC-4EB2-8A94-21C98AE7C7A4

P356

Q26851802-715F605C-841D-4151-BFFA-485B0C58AFDA

P407

Q26851802-2DE268FA-3EE7-4CF8-8F11-1F840AAA3FA0

P433

Q26851802-D2E36D21-B545-46AE-B9E6-327D6A051BCE

P478

Q26851802-5AC8868A-74A5-42F3-B7FA-4B8690982110

P50

Q26851802-138C6C7F-D35A-4E57-96BB-A438F44F22AD

Q26851802-5D490B6F-4020-42E7-AD06-050688E53B4C

P577

Q26851802-397B5404-4BE4-4C15-9DD6-38A88DA933B9

P698

Q26851802-FB2D386B-A8BF-4020-9A1D-BA30EA715558

P3181

P356

P1433

European Journal of Endocrinology

P1476

Endocrine side-effects of anti ...... ence and pathogenic hypotheses

@en

P2093

Francesco Torino

http://www.w3.org/2001/XMLSchema#string

Roberto Salvatori

http://www.w3.org/2001/XMLSchema#string

Rosa Maria Paragliola

http://www.w3.org/2001/XMLSchema#string

Salvatore Maria Corsello

http://www.w3.org/2001/XMLSchema#string

P304

R153-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3086639

http://www.w3.org/2001/XMLSchema#string

P356

10.1530/EJE-13-0434

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Marchetti

Agnese Barnabei

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24001893

http://www.w3.org/2001/XMLSchema#string